---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-082414"
form_type: "8-K"
ticker: "CTSO"
cik: "0001175151"
company_name: "Cytosorbents Corp"
filed_at: "2023-07-19T23:59:59+00:00"
generated_at: "2026-06-13T06:15:50.943360+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CytoSorbents appoints Alexander D'Amico as CFO effective August 7, 2023

## Summary
- Annual base salary of $425,000; eligible for cash bonus up to 45% of salary based on milestones.
- Received signing bonus of $5,000 and equity awards including 70,000 ISOs, 45,000 RSUs, 215,000 performance ISOs.
- Employment agreement initial term through Dec 31, 2025, auto-renewing annually thereafter.
- D'Amico previously CFO of Trulieve Cannabis; oversaw finance during revenue growth from $250M to $1.2B.
- Outgoing CFO Kathy Bloch retiring after decade of service; transition managed.

## SEC filing metadata
- accession: 0001104659-23-082414
- form_type: 8-K
- ticker: CTSO
- cik: 0001175151
- company_name: Cytosorbents Corp
- filed_at: 2023-07-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175151/000110465923082414/0001104659-23-082414-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175151/000110465923082414/tm2321613d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-082414
- JSON: https://secwatch.observer/filing/0001104659-23-082414.json
- Plain text: https://secwatch.observer/filing/0001104659-23-082414.txt

## Key facts
- Executive change
  Alexander D'Amico was appointed as Chief Financial Officer at Cytosorbents Corp.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Mr. D’Amico will serve as the Company’s Chief Financial Officer, effective as of August 7, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175151/000110465923082414/0001104659-23-082414-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.